Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat
about
In vitro nuclear interactome of the HIV-1 Tat proteinTranscriptional repression of human immunodeficiency virus type 1 by AP-4The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoterExpression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acidRegulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoterYY1 and FoxD3 regulate antiretroviral zinc finger protein OTK18 promoter activation induced by HIV-1 infectionRecruitment of Tat to heterochromatin protein HP1 via interaction with CTIP2 inhibits human immunodeficiency virus type 1 replication in microglial cellsImpact of Chromatin on HIV ReplicationPost-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virusTranscriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cureDepletion of latent HIV-1 infection in vivo: a proof-of-concept studyTargeted derepression of the human immunodeficiency virus type 1 long terminal repeat by pyrrole-imidazole polyamides.Epigenetic regulation of a murine retrotransposon by a dual histone modification markHIV promoter integration site primarily modulates transcriptional burst size rather than frequencyLatency reversal and viral clearance to cure HIV-1.Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells.Recruitment and activation of RSK2 by HIV-1 TatControl of stochastic gene expression by host factors at the HIV promoter.Yeast genetic analysis reveals the involvement of chromatin reassembly factors in repressing HIV-1 basal transcriptionEpstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene BimSynergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.CpG methylation controls reactivation of HIV from latency.Biphasic recruitment of transcriptional repressors to the murine cytomegalovirus major immediate-early promoter during the course of infection in vivoDisplacement of SATB1-bound histone deacetylase 1 corepressor by the human immunodeficiency virus type 1 transactivator induces expression of interleukin-2 and its receptor in T cells.Combinatorial latency reactivation for HIV-1 subtypes and variantsThe Human Immunodeficiency Virus 1 ASP RNA promotes viral latency by recruiting the Polycomb Repressor Complex 2 and promoting nucleosome assemblyRepressive LTR nucleosome positioning by the BAF complex is required for HIV latency.A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs.Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription.Selective histonedeacetylase inhibitor M344 intervenes in HIV-1 latency through increasing histone acetylation and activation of NF-kappaBRecruitment of SWI/SNF to the human immunodeficiency virus type 1 promoterHexamethylbisacetamide remodels the human immunodeficiency virus type 1 (HIV-1) promoter and induces Tat-independent HIV-1 expression but blunts cell activationInnate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation.HIV-1 regulatory proteins: targets for novel drug development.Differential HIV-1 replication in neonatal and adult blood mononuclear cells is influenced at the level of HIV-1 gene expression.Viral-host interactions that control HIV-1 transcriptional elongationHigh-frequency epigenetic repression and silencing of retroviruses can be antagonized by histone deacetylase inhibitors and transcriptional activators, but uniform reactivation in cell clones is restricted by additional mechanisms.The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.Lineage-specific and ubiquitous biological roles of the mammalian transcription factor LSFThe transposon-driven evolutionary origin and basis of histone deacetylase functions and limitations in disease prevention.
P2860
Q21245051-74E8DB2D-3E52-4973-AC1B-B3FF4F31D7D8Q24307916-D3172202-3918-4809-8A58-8FDF0F2E9A4EQ24336893-41A75B8A-D2D8-4531-9524-B6FF937A76BBQ24596282-539EB54B-4227-450B-948E-6B7A2F50DB17Q24634457-C5AC5ABC-421F-4922-A579-BE78F3FD7DFFQ24646624-23B6DD02-604A-46B7-91FF-C2BFC32CDB29Q24679559-16B086BE-596C-4240-A19E-00A4E41EB13BQ26782046-97675EFD-1600-4CE7-81E8-3B7A2835CF65Q26797870-4DBE4381-38C0-4F7A-BA46-CAA9CE853AF9Q26999858-E97C0C23-7768-4638-B917-3992AA2C038BQ28111910-794527FD-9885-49A9-A388-748C41395AF5Q28213125-A262DC82-087A-4A67-B2CC-0C13F040A4A0Q28473811-D5CA25A9-4566-4CF2-AA82-A775E1619288Q28475647-32B55D0B-2DF5-4045-A53F-F602C4536542Q30248766-BED1DC88-A20A-40C8-8461-63D061F8992EQ33250088-656C3EB3-71F3-4D0B-827E-AD88E5D9CB84Q33269333-2EB4BD2A-9EF0-4757-85C0-26CEAC535B0BQ33398516-95CB8E8E-A6B0-4067-9C1B-727074C9CDC4Q33400343-CDCDB6ED-0014-416B-8506-0C96989EA39EQ33474807-2829529C-B092-428E-903A-70D4B236E4E7Q33476165-53340325-FBFD-4C92-BF09-13BE78F18901Q33495565-E1D9A474-DA1D-4644-8CDD-5C8295B4945AQ33725662-1B287E5A-535C-4097-BF4E-15686DC9B3ADQ33860989-0F7B91F9-A218-4BAF-A634-0A6EFD7119D3Q33877492-24A0E365-28E3-4D38-BB72-636ABA78A48DQ33893725-D0E9B2E4-B48A-43B8-8569-7D69B21B27DAQ34090863-F03C86E7-4049-4334-8F2C-641A0AFCB62BQ34145909-3B38AEA2-0B0D-4676-9632-B327AA941EB5Q34350588-2341867D-AD70-4EC6-B810-582BE10F3C05Q34482017-7DFB199F-B700-45CB-AEF2-D7D4C2A1E0DFQ34551968-D613291E-2867-4153-B54B-97486934B9E5Q34647406-6BF1417D-ED05-43FB-9F26-C57624FC9FB5Q34671609-0CC154DF-2F40-4495-A6D8-AD4C0B1B52BBQ34768563-B86924C8-46D4-433F-9070-F7CAE2D62220Q34984509-D5A9AE41-55BB-4294-81DA-F070D5F70688Q35026881-6E74D565-67A2-4797-AA2D-1D0F6D0AB30AQ35784937-3DA2F71E-5183-49AC-8B2F-B1A95743B1B4Q35829282-EB1E3878-D4DF-4EB8-9579-4D024DD7B104Q35962753-DCB1DEBD-ED5C-43AA-B90C-B06D3D889BC5Q36001865-C728A98B-22C7-41E5-9983-44E444EDD18A
P2860
Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Counterregulation of chromatin ...... or YY1 and HIV-1 activator Tat
@ast
Counterregulation of chromatin ...... or YY1 and HIV-1 activator Tat
@en
Counterregulation of chromatin ...... or YY1 and HIV-1 activator Tat
@nl
type
label
Counterregulation of chromatin ...... or YY1 and HIV-1 activator Tat
@ast
Counterregulation of chromatin ...... or YY1 and HIV-1 activator Tat
@en
Counterregulation of chromatin ...... or YY1 and HIV-1 activator Tat
@nl
prefLabel
Counterregulation of chromatin ...... or YY1 and HIV-1 activator Tat
@ast
Counterregulation of chromatin ...... or YY1 and HIV-1 activator Tat
@en
Counterregulation of chromatin ...... or YY1 and HIV-1 activator Tat
@nl
P2860
P3181
P1476
Counterregulation of chromatin ...... or YY1 and HIV-1 activator Tat
@en
P2093
Guocheng He
P2860
P304
P3181
P356
10.1128/MCB.22.9.2965-2973.2002
P407
P577
2002-05-01T00:00:00Z